Cilostazol inhibits endothelin-induced calcium increase and vasoconstriction in mouse intracranial arteries. a. by Yoshifumi Kawanabe (308848)

“…Arrows denote basilar artery constriction. Bar = 50 µm <b>c.</b> Cilostazol significantly decreases endothelin-induced cytosolic calcium increase. …”

Different defense-disease relations illustrated by a ‘see-saw but see-see’ model. by Alexander Kröner (346297)

The in vitro and in vivo effect of a chemokine inhibitor CTCE-9908 in combination with Kynurenine metabolites on tumour adhesion by Danielle Tatchum (16946574)

“…In the non-cancerous cell lines HaCaT and EA. hy926, there was a decrease in percentage cell number after treatment with L-kyn, phorbol 12-myristate 13-acetate (PMA), a positive control for adhesion, and CTCE-9908, suggesting a decrease in cell adhesion in the non-cancerous cell lines.…”

Joey Tan: The role of preptin in the response of bone tissue to a high-fat diet by Joey Tan (11499238)

Evaluation of developmental toxicity and teratogenicity. by Shen Huang (9967526)

RICTOR silencing inhibits cell proliferation via UGCG regulation. by Mohammad Nafees Ansari (22232505)

“…(<b>F</b>) Fold change (mean ± SEM, <i>n</i> = 5) in different sphingolipid species reveals an increase in ceramides and a decrease in glucosylceramides in MCF-7_RICTOR^SH cells compared to MCF-7 cells. …”

DNA double strand break levels increase with age in <i>fog-2</i> feminized germlines. by Erik Toraason (5724689)

Fig 3 - by Sara Hintze (3216885)

Effects of bortezomib on total OATP1B1 and OATP1 B3 protein levels and total ubiquitin-conjugated proteins in human SCH. by Khondoker Alam (1443499)

Total lipid contents of ovaries from queens sampled at different seasonal time points. by Mark J. Carroll (3605582)

Percentage of living PC3 cells in presence of DRS-B2 and sodium chlorate. by Célia Dos Santos (306471)

Effects of lysosome inhibitor chloroquine on total protein levels of OATP1B3 in HEK293-OATP1B3 cells and human SCH. by Khondoker Alam (1443499)

Synthesis and characterization of dendrimer-cysteamine nano-formulation. by Scott Mackenzie Brockman (4433614)

Measurements of body mass index (BMI) and adipose deposits. by Jessica C. M. Hui (20370522)

Effect of cGAS deficiency on picornaviruses replication <i>in vitro</i>. by Huisheng Liu (408091)

Data_Sheet_1_Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial.docx by Tatsuhiko Wada (14391781)

“…</p>Results<p>Overall, 112 and 109 patients were randomized to ivermectin and placebo, respectively; 106 patients from each group were included in the full analysis set (male [%], mean age: 68.9%, 47.9 years [ivermectin]; 62.3%, 47.5 years [placebo]). …”

Data_Sheet_1_Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial.docx by Tatsuhiko Wada (14391781)

“…</p>Results<p>Overall, 112 and 109 patients were randomized to ivermectin and placebo, respectively; 106 patients from each group were included in the full analysis set (male [%], mean age: 68.9%, 47.9 years [ivermectin]; 62.3%, 47.5 years [placebo]). …”

Data_Sheet_1_Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial.docx by Tatsuhiko Wada (14391781)

“…</p>Results<p>Overall, 112 and 109 patients were randomized to ivermectin and placebo, respectively; 106 patients from each group were included in the full analysis set (male [%], mean age: 68.9%, 47.9 years [ivermectin]; 62.3%, 47.5 years [placebo]). …”

Receiver position and time error applying range difference method. by Jae Hwan Bong (17054738)

Transition matrix of LULC change (ha) between 1999 and 2009. by Ajit Kumar Rudra (21647706)